Active, Not Recruiting
Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment
NCT05261399
- Conditions
- Carcinoma, Neoplasm Metastasis, Neoplasms, +6 more
- Locations
-
- Research Site Orlando, Florida, United States
- Research Site Honolulu, Hawaii, United States
- Research Site New Brunswick, New Jersey, United States
- Research Site New York, United States